Encapsulated calcium carbonate suspensions: A drug delivery vehicle sensitive to ultrasound disruption

8Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

A calcium carbonate suspension, encapsulated within particles of calcium alginate hydrogel, is proposed as a drug delivery device susceptible to ultrasound disruption. Spheres approximately 1mm in diameter were prepared by the coaxial airflow method from mixtures of 1% sodium alginate (m/v) and each of 50%, 75% and 100% calcium carbonate (m/v) in distilled water. This product was subjected to cycles of 85 Watt ultrasound in 1 second on/off bursts via a lab sonication system until fully disintegrated, a process requiring between 8 and 20 minutes depending upon initial calcium carbonate concentrations. The spheres subjected to vortex did not demonstrate any signs of mechanical degeneration after 30 minutes. Before use as a model implant, further work is required to develop a method of drying the particles to make them impermeable to drug diffusion before the time of their disruption with ultrasound. Copyright © 2006 by MJM.

Cite

CITATION STYLE

APA

Lanting, B., & Barfett, J. (2006). Encapsulated calcium carbonate suspensions: A drug delivery vehicle sensitive to ultrasound disruption. McGill Journal of Medicine, 9(2), 108–110. https://doi.org/10.26443/mjm.v9i2.441

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free